Periodontists and stem cell‐based therapy for alveolar bone regeneration: A national survey

Abstract

AbstractBackgroundStem cell‐based therapy for bone regeneration has received attention in medical settings but has not yet been used in clinical practice for treating alveolar bone defects. The objectives of this study were to explore whether periodontists had heard about this approach, and if so how, how interested they were to learn about it, which attitudes and behavioral intentions they had related to using stem cell‐based grafting, and what they would like to know before using this approach.MethodsAnonymous survey data were collected from 481 members of the American Academy of Periodontology (response rate: 19.41%).ResultsResponses showed 35.3% had heard about stem cell‐based therapy, mostly from publications (9.6%) and meetings (8.3%); 76.1% wanted to learn about it through in‐person continuing education (CE) courses, 68.6% in online CE courses, and 57.1% from manuals; 73% considered this approach promising; and 54.9% preferred it to traditional approaches. It was important to them that it would result in more bone volume (93%), better bone quality (90.4%), and accelerated healing (83.2%). Also, 60.1% considered it likely/very likely that they would adopt this approach, 54% that patients would prefer it, and 62.1% that it would benefit their practice. When asked what they would like to know about this approach, information about short‐ and long‐term outcomes, cost, and logistical considerations were most frequently named.ConclusionsThese findings provide the basis to develop educational interventions for periodontists about this novel approach and inform future research activities aimed to translate this approach to clinical practice.